CLOSE X

EMCURE PHARMACEUTICALS LTD.

NSE : EMCUREBSE : 544210ISIN CODE : INE168P01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE2015.75105.65 (+5.53 %)
PREV CLOSE ( ) 1910.10
OPEN PRICE ( ) 1912.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 86374
TODAY'S LOW / HIGH ( )1911.95 2101.00
52 WK LOW / HIGH ( )1260.1 2101
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 16-04 1981
Management Info
Berjis Desai - Chairman Satish Mehta - Managing Director
Registered Office

Address Plot No. P-1 & P-2,I T - B T Park, Phase- I I,M I D C, Hinjawadi,
Pune,
Maharashtra-411057

Phone 020-35070033 / 35070000

Email corporate@emcure.com

Website www.emcure.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
10Aug Emcure Pharmaceuticals gets EIR from U
Emcure Pharmaceuticals has received the Establishment Inspection Report..
10Aug Emcure Pharmaceuticals moves up on get
Emcure Pharmaceuticals is currently trading at Rs. 1987.10, up by 10.00..
21Jul Emcure gets nod to market Poviztra for
Emcure Pharmaceuticals has secured Central Drugs Standard Control Organi..
21Jul Emcure soars on getting nod to market
Emcure Pharmaceuticals is currently trading at Rs. 1909.50, up by 48.80..
14Jul Emcure Pharmaceuticals to acquire rema
Emcure Pharmaceuticals has inked pact to acquire remaining 12.05% stake..
Financials
Rs. in Millions
QTR Jun 26 ANNUAL 26
Net Profit2001.087329.59
Gross Profit 2686.73 9441.91
Operating Profit 3646.1513342.66
Net Sales 14509.3152431.88
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 27273.30 (5.26%)
M.Cap ( in Cr)57953.86
Neuland Laboratories (BSE)
 22875.70 (0.97%)
M.Cap ( in Cr)29349.27
Alkem Laboratories (BSE)
 5501.60 (3.03%)
M.Cap ( in Cr)65779.88
Caplin Point Labs. (BSE)
 2747.85 (5.87%)
M.Cap ( in Cr)20886.87
Acutaas Chemicals (BSE)
 3438.15 (3.70%)
M.Cap ( in Cr)28148.52
Shareholding Pattern
PROMOTERS 77.83%
NON-INSTITUTION 8.83%
MUTUAL FUNDS/UTI 6.87%
FI/BANKS/INSURANCE 1.34%
GOVERNMENT 0%
FII 0%
Advisory for Investors Complaints Data August 2026 Broking Complaints Data August 2026 DP

Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & quick

  • > Register On SCORES / SMARTODR Portal
  • > Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
  • > Benefits:
    • Effective communication
    • Speedy Redressal of Grievance / Dispute
  • http://scores.sebi.gov.in
  • https://smartodr.in/login
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002
  • 6)Verified UPI ID for receiving Payments: badjate.rzp1.brk@validhdfc
  • 7)Click here for QR Code

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.